BioPharma Dive

GSK walks away from pioneering Wave RNA editing drug

Wave claimed GSK is walking away from the frontrunning program not because of questions about its potential, but because Wave ...
Fierce Biotech

GSK gives back rights to Wave's genetic disease RNA editor

Wave Life Sciences has the fate of its lead RNA editing candidate back in its own hands. | Wave Life Sciences has the fate of its lead RNA editing candidate back in its own hands. GSK has decided not ...
BioSpace

Wave To Work Alone on RNA Editor as AATD Picture Becomes Clearer

After GSK’s return of Wave Life Sciences’ WVE-006 as well as the mid-stage failure of Korro Bio’s candidate, the alpha-1 ...
Electronic Design

Test & Measurement: Analog Waveform Editor Speeds Up Test-Signal Creation And Editing

Handling waveforms up to 1 Gsample/s, the Analog Waveform Editor with intelligent hard-disk caching enables design and test engineers to rapidly create and edit test signals. It seamlessly integrates ...